1887

Abstract

Purpose. This study was aimed at investigating the occurrence and genetic mechanisms of resistance to ciprofloxacin, tetracycline and erythromycin in clinical isolates of Campylobacter jejuni recovered from human cases of acute gastroenteritis in Turkey.

Methodology. MIC values of each antibiotic were determined with the epsilometer test (E-test). Resistance genes/mutations were first screened by PCR and analysed by subsequent DNA sequencing.

Results. From a total of 152 C. jejuni isolates tested, 113 (74.3%), 38 (25%) and 9 (5.9%) were found to be resistant to ciprofloxacin, tetracycline and erythromycin, respectively. Sequence analysis of ciprofloxacin-resistant isolates showed that all resistant strains (n=113) carried Thr-86-Ile substition in the gyrA gene, which is the most frequently observed mutation in fluoroquinolone-resistant Campylobacter . All of the tetracycline-resistant isolates (n=38) carried the tetO gene. All of the erythromycin-resistant isolates (n=9) harboured the point mutation A2075G in the 23S rRNA gene, which is the most common mutation conferring macrolide resistance in C. jejuni .

Conclusion. The phenotypic susceptibility testing results were found to agree well with those obtained by genetic detection methods for the C. jejuni isolates tested. The findings of this study showed a very high level of resistance to ciprofloxacin and to a lesser extent to tetracycline while resistance to erythromycin remained at a low level. Thus, erythromycin may be considered as the first choice for treatment of Campylobacter infections in this geographical region when indicated.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000890
2018-12-12
2019-10-15
Loading full text...

Full text loading...

References

  1. Lehtopolku M, Hakanen AJ, Siitonen A, Huovinen P, Kotilainen P. In vitro activities of 11 fluoroquinolones against 226 Campylobacter jejuni strains isolated from Finnish patients, with special reference to ciprofloxacin resistance. J Antimicrob Chemother 2005;56:1134–1138 [CrossRef][PubMed]
    [Google Scholar]
  2. Bassal R, Lerner L, Valinsky L, Agmon V, Peled N et al. Trends in the epidemiology of campylobacteriosis in Israel (1999-2012). Foodborne Pathog Dis 2016;13:448–455 [CrossRef][PubMed]
    [Google Scholar]
  3. Allos BM. Campylobacter jejuni Infections: update on emerging issues and trends. Clin Infect Dis 2001;32:1201–1206 [CrossRef][PubMed]
    [Google Scholar]
  4. Blaser MJ, Engberg J. Clinical aspects of Campylobacter jejuni and Campylobacter coli infections. In Nachamkin I, Szymanski C, Blaser M. (editors) Campylobacter, 3rd ed. Washington, DC: ASM Press; 2008
    [Google Scholar]
  5. Engberg J, Aarestrup FM, Taylor DE, Gerner-Smidt P, Nachamkin I. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates. Emerg Infect Dis 2001;7:24–34 [CrossRef][PubMed]
    [Google Scholar]
  6. Sahin O, Shen Z, Zhang Q. Methods to study antimicrobial resistance in campylobacter jejuni, chapter 4. In Butcher James. (editor) Campylobacter Jejuni: Methods and Protocols, Methods in Molecular Biologyvol. 1512 New York: Springer Science+Business Media; 2017
    [Google Scholar]
  7. Cha W, Mosci R, Wengert SL, Singh P, Newton DW et al. Antimicrobial susceptibility profiles of human Campylobacter jejuni isolates and association with phylogenetic lineages. Front Microbiol 2016;7:1–12 [CrossRef][PubMed]
    [Google Scholar]
  8. Wieczorek K, Osek J. Antimicrobial resistance mechanisms among Campylobacter. Biomed Res Int 2013;340605:
    [Google Scholar]
  9. Kayman T, Abay S, Hızlısoy H. [Identification of Campylobacter spp. isolates with phenotypic methods and multiplex polymerase chain reaction and their antibiotic susceptibilities]. Mikrobiyol Bul 2013;47:230–239 [CrossRef][PubMed]
    [Google Scholar]
  10. CLSI Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria, Approved Guideline-Second ed. Wayne, PA: 2010; (M45-A2 Vol. 30 No. 18 replaces M45-A Vol. 26 No. 19)
    [Google Scholar]
  11. European Committee on Antimicrobial Susceptibility Testing (EUCAST) Antimicrobial wild type distributions of microorganisms. 2018; Available athttps://mic.eucast.org/Eucast2/SearchController/search.jsp?action=performSearch&BeginIndex=0&Micdif=mic&NumberIndex=50&Antib=-1&Specium=204
  12. Zirnstein G, Li Y, Swaminathan B, Angulo F. Ciprofloxacin resistance in Campylobacter jejuni isolates: detection of gyrA resistance mutations by mismatch amplification mutation assay PCR and DNA sequence analysis. J Clin Microbiol 1999;37:3276–3280[PubMed]
    [Google Scholar]
  13. El-Adawy H, Hotzel H, Düpre S, Tomaso H, Neubauer H et al. Determination of antimicrobial sensitivities of Campylobacter jejuni isolated from commercial turkey farms in Germany. Avian Dis 2012;56:685–692 [CrossRef][PubMed]
    [Google Scholar]
  14. Alonso R, Mateo E, Churruca E, Martinez I, Girbau C et al. MAMA-PCR assay for the detection of point mutations associated with high-level erythromycin resistance in Campylobacter jejuni and Campylobacter coli strains. J Microbiol Methods 2005;63:99–103 [CrossRef][PubMed]
    [Google Scholar]
  15. Gibreel A, Tracz DM, Nonaka L, Ngo TM, Connell SR et al. Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet(O)-mediated tetracycline resistance. Antimicrob Agents Chemother 2004;48:3442–3450 [CrossRef][PubMed]
    [Google Scholar]
  16. Ongen B, Nazik H. Investigation of plasmid mediated quinolone resistance among Campylobacter strains. Farmaci e Terapia 2008;25:37–39
    [Google Scholar]
  17. Gur D, Hasçelik G, Akyon Y, Akalın HE, Diker S. Campylobacter jejuni ve Campylobacter coli’nin quinolone grubu antibiyotiklere in vitro duyarlılıkları. Mikrobiyol Bul 1989;23:185–189
    [Google Scholar]
  18. Arikan Akan O, Hasçelik G, Akyön Y, Yurdakök K. Campylobacter türlerinin çeşitli antibiyotiklere in vitro duyarlılığı. Mikrobiyol Bul 1994;28:122–126
    [Google Scholar]
  19. Yıldırım MS, Sümerkan B, Fazli SA. Dışkı kültürlerinden izole edilen Campylobacter türlerinin antimikrobiyal ajanlara duyarlılıkları. ANKEM 1996;10:393–398
    [Google Scholar]
  20. Oncul O, Zarakolu P, Oncul O, Gur D. Antimicrobial susceptibility testing of Campylobacter jejuni: a comparison between Etest and agar dilution method. Diagn Microbiol Infect Dis 2003;45:69–71 [CrossRef][PubMed]
    [Google Scholar]
  21. Ongen B, Nazik H, Kaya I. Rutin dışkı kültürlerinde üretilen Campylobacter türleri ve antibiyotik duyarlılıkları: 5 yıllık sonuçların değerlendirilmesi. ANKEM 2007;21:37–41
    [Google Scholar]
  22. Guney M, Başustaoğlu AC. Gülhane Askeri Tıp Akademisi Eğitim Hastanesi’nde akut bakteriyel gastroenterit etkenleri arasinda Campylobacter jejuni ve Campylobacter coli’nin yeri ve bunların antimikrobiklere duyarlılıklarının araştırılması. Türk Mikrobiyol Cem Derg 2010;40:183–192
    [Google Scholar]
  23. Cody AJ, Clarke L, Bowler IC, Dingle KE. Ciprofloxacin-resistant campylobacteriosis in the UK. Lancet 2010;376:1987 [CrossRef][PubMed]
    [Google Scholar]
  24. Sáenz Y, Zarazaga M, Lantero M, Gastanares MJ, Baquero F et al. Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998. Antimicrob Agents Chemother 2000;44:267–271 [CrossRef][PubMed]
    [Google Scholar]
  25. Corcoran D, Quinn T, Cotter L, Whyte P, Fanning S. Antimicrobial resistance profiling and fla-typing of Irish thermophillic Campylobacter spp. of human and poultry origin. Lett Appl Microbiol 2006;43:560–565 [CrossRef][PubMed]
    [Google Scholar]
  26. Wardak S, Szych J, Zasada AA, Gierczynski R. Antibiotic resistance of Campylobacter jejuni and Campylobacter coli clinical isolates from Poland. Antimicrob Agents Chemother 2007;51:1123–1125 [CrossRef][PubMed]
    [Google Scholar]
  27. Rozynek E, Dzierzanowska-Fangrat K, Korsak D, Konieczny P, Wardak S et al. Comparison of antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolated from humans and chicken carcasses in Poland. J Food Prot 2008;71:602–607 [CrossRef][PubMed]
    [Google Scholar]
  28. Lehtopolku M, Nakari UM, Kotilainen P, Huovinen P, Siitonen A et al. Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents. Antimicrob Agents Chemother 2010;54:1232–1236 [CrossRef][PubMed]
    [Google Scholar]
  29. Feodoroff B, Ellström P, Hyytiäinen H, Sarna S, Hänninen ML et al. Campylobacter jejuni isolates in Finnish patients differ according to the origin of infection. Gut Pathog 2010;2:22 [CrossRef][PubMed]
    [Google Scholar]
  30. Woźniak A, Kuczkowski M, Chrząstek K, Mazurkiewicz M, Wardak S et al. Prevalence of mutation in gyrA gene at Thr-86 position in Campylobacter jejuni and Campylobacter coli isolated from poultry and humans. Bull Vet Inst Pulawy 2011;55:391–395
    [Google Scholar]
  31. Kittl S, Kuhnert P, Hächler H, Korczak BM. Comparison of genotypes and antibiotic resistance of Campylobacter jejuni isolated from humans and slaughtered chickens in Switzerland. J Appl Microbiol 2011;110:513–520 [CrossRef][PubMed]
    [Google Scholar]
  32. Niederer L, Kuhnert P, Egger R, Büttner S, Hächler H et al. Genotypes and antibiotic resistances of Campylobacter jejuni and Campylobacter coli isolates from domestic and travel-associated human cases. Appl Environ Microbiol 2012;78:288–291 [CrossRef][PubMed]
    [Google Scholar]
  33. Duarte A, Santos A, Manageiro V, Martins A, Fraqueza MJ et al. Human, food and animal Campylobacter spp. isolated in Portugal: high genetic diversity and antibiotic resistance rates. Int J Antimicrob Agents 2014;44:306–313 [CrossRef][PubMed]
    [Google Scholar]
  34. Hormeño L, Palomo G, Ugarte-Ruiz M, Porrero MC, Borge C et al. Identification of the main quinolone resistance determinant in Campylobacter jejuni and Campylobacter coli by MAMA-DEG PCR. Diagn Microbiol Infect Dis 2016;84:236–239 [CrossRef][PubMed]
    [Google Scholar]
  35. Szczepanska B, Andrzejewska M, Spica D, Klawe JJ. Prevalence and antimicrobial resistance of Campylobacter jejuni and Campylobacter coli isolated from children and environmental sources in urban and suburban areas. BMC Microbiol 2017;17:80 [CrossRef][PubMed]
    [Google Scholar]
  36. Sonnevend A, Rotimi VO, Kolodziejek J, Usmani A, Nowotny N et al. High level of ciprofloxacin resistance and its molecular background among Campylobacter jejuni strains isolated in the United Arab Emirates. J Med Microbiol 2006;55:1533–1538 [CrossRef][PubMed]
    [Google Scholar]
  37. Hamidian M, Sanaei M, Azimi-Rad M, Tajbakhsh M, Dabiri H et al. fla-typing, RAPD analysis, isolation rate and antimicrobial resistance profile of Campylobacter jejuni and Campylobacter coli of human origin collected from hospitals in Tehran, Iran. Ann Microbiol 2011;61:315–321 [CrossRef]
    [Google Scholar]
  38. Said MM, El-Mohamady H, El-Beih FM, Rockabrand DM, Ismail TF et al. Detection of gyrA mutation among clinical isolates of Campylobacter jejuni isolated in Egypt by MAMA-PCR. J Infect Dev Ctries 2010;4:546–554 [CrossRef][PubMed]
    [Google Scholar]
  39. Randrianirina F, Ratsima EH, Ramparany L, Randremanana R, Rakotonirina HC et al. Antimicrobial resistance of bacterial enteropathogens isolated from stools in Madagascar. BMC Infect Dis 2014;14:104 [CrossRef][PubMed]
    [Google Scholar]
  40. Ku BK, Kim HJ, Lee YJ, Kim YI, Choi JS et al. Genetic characterization and antimicrobial susceptibility of Campylobacter spp. isolated from domestic and imported chicken meats and humans in Korea. Foodborne Pathog Dis 2011;8:381–386 [CrossRef][PubMed]
    [Google Scholar]
  41. Ghosh R, Uppal B, Aggarwal P, Chakravarti A, Jha AK. Increasing antimicrobial resistance of campylobacter jejuni isolated from paediatric diarrhea cases in a tertiary care hospital of new delhi, India. J Clin Diagn Res 2013;7:247–249 [CrossRef][PubMed]
    [Google Scholar]
  42. Pham NT, Thongprachum A, Tran DN, Nishimura S, Shimizu-Onda Y et al. Antibiotic Resistance of Campylobacter jejuni and C. coli Isolated from Children with Diarrhea in Thailand and Japan. Jpn J Infect Dis 2016;69:77–79 [CrossRef][PubMed]
    [Google Scholar]
  43. Chang YC, Tien N, Yang JS, Lu CC, Tsai FJ et al. Class 1 integrons and plasmid-mediated multiple resistance genes of the Campylobacter species from pediatric patient of a university hospital in Taiwan. Gut Pathog 2017;9:50 [CrossRef][PubMed]
    [Google Scholar]
  44. Riley A, Eshaghi A, Olsha R, Allen VG, Patel SN. Antibiotic susceptibility of clinical isolates of Campylobacter jejuni and Campylobacter coli in Ontario, Canada during 2011-2013. Diagn Microbiol Infect Dis 2015;83:292–294 [CrossRef][PubMed]
    [Google Scholar]
  45. Savasan S, Ciftci A, Diker KS. Emergence of quinolone resistance among chicken isolates of Campylobacter in Turkey. Turk J Vet Anim Sci 2004;28:391–397
    [Google Scholar]
  46. Smith JL, Fratamico PM. Fluoroquinolone resistance in campylobacter. J Food Prot 2010;73:1141–1152 [CrossRef][PubMed]
    [Google Scholar]
  47. Ozturk R, Midilli K, Okyay K, Eroğlu C, Aygün G et al. Çocuk ve erişkin yaş grubu sürgün olgularında Campylobacter jejuni ve Campylobacter coli sıklığının araştırılması. Turk Mikrobiyol Cem Derg 1994;24:42–45
    [Google Scholar]
  48. Yılmaz AT, Tuğrul HM. Edirne’de ishal etkenleri arasında Campylobacter türlerinin yerinin ve antimikrobiklere duyarlılıklarının araştırılması. Infeksiyon Derg 2005;19:53–59
    [Google Scholar]
  49. Lehtopolku M, Kotilainen P, Haanperä-Heikkinen M, Nakari UM, Hänninen ML et al. Ribosomal mutations as the main cause of macrolide resistance in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother 2011;55:5939–5941 [CrossRef][PubMed]
    [Google Scholar]
  50. Schönberg-Norio D, Hänninen ML, Katila ML, Kaukoranta SS, Koskela M et al. Activities of telithromycin, erythromycin, fluoroquinolones, and doxycycline against Campylobacter strains isolated from Finnish subjects. Antimicrob Agents Chemother 2006;50:1086–1088 [CrossRef][PubMed]
    [Google Scholar]
  51. Gibreel A, Kos VN, Keelan M, Trieber CA, Levesque S et al. Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob Agents Chemother 2005;49:2753–2759 [CrossRef][PubMed]
    [Google Scholar]
  52. Dasti JI, Gross U, Pohl S, Lugert R, Weig M et al. Role of the plasmid-encoded tet(O) gene in tetracycline-resistant clinical isolates of Campylobacter jejuni and Campylobacter coli. J Med Microbiol 2007;56:833–837 [CrossRef][PubMed]
    [Google Scholar]
  53. Yıldırım M, Istanbulluoglu E, Ayvalı B, Unal N. Comparison of Disc diffusion and E test for in vitro antimicrobial susceptibility testing of Campylobacter jejuni and Campylobacter coli isolated from poultry. Revue Méd Vét 2005;156:510–513
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000890
Loading
/content/journal/jmm/10.1099/jmm.0.000890
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error